Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Comparing two regional anesthesia techniques for knee replacement

Official title: Comparison of the Effects of Ultrasound-Guided Adductor Canal Block With iPACK (Space Between the Popliteal Artery and the Posterior Knee Capsule) Block Combination and Suprainguinal Fascia Iliaca Block on Postoperative Pain and Stress Response in Patients Undergoing Total Knee Arthroplasty

Run by SB Istanbul Education and Research Hospital · NCT07092982 · Data updated 2026-11-12

This trial tests whether ultrasound-guided supra-inguinal fascia iliaca block or ultrasound-guided adductor canal block (with iPACK as part of the regimen) gives better pain control and less opioid use for adults having total knee replacement.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment52 (estimated)
SponsorSB Istanbul Education and Research Hospital
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedAugust 4, 2025
Main results expectedJuly 1, 2026
Study endsJuly 2026
Registry record updatedApril 6, 2026
Trial IDNCT07092982 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 undergoing total knee arthroplasty with ASA I–III who can consent and have no contraindications to nerve blocks are ideal candidates.

Probably not a fit

Patients with coagulation disorders, active infection at the block site, pre-existing neurologic deficits, severe liver or renal failure, long-term analgesic use, or other contraindications to nerve block are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults scheduled for total knee arthroplasty will receive ultrasound-guided peripheral nerve blocks as part of their postoperative analgesia, using either a supra-inguinal fascia iliaca approach or an adductor canal approach, with an iPACK block used in the regimen. The trial will monitor postoperative pain scores, opioid consumption, early mobilization, and block-related complications. Eligible participants are adults 18–75 with ASA physical status I–III and without contraindications to regional anesthesia. Data will be used to compare pain control effectiveness and secondary outcomes such as nausea, vomiting, and length of stay.

Why it matters

Potential benefit: If successful, the preferred block could improve postoperative pain control, reduce opioid use, and speed recovery after knee replacement.

How similar studies have gone: Adductor canal plus iPACK techniques have shown benefit in total knee arthroplasty in prior work, while the use of supra-inguinal fascia iliaca block for this operation is less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing total knee arthroplasty
* Patients aged 18-75
* Patients with ASA I-II-III

Exclusion Criteria:

* Coagulation disorders
* Allergy to local anesthetics
* Liver and renal failure
* Alcohol and drug addiction
* Cognitive dysfunction that may prevent pain assessment
* Systemic or needle insertion site infection
* Analgesic use for more than 3 months
* Patient refusal to participate in the study/refusal to consent
* Presence of a hematoma, hernia, neoplasm, etc. in the area where the block will be performed
* Pre-existing neurological deficit
* Patients with contraindications to nerve block

Where it's running

  • SB Istanbul Education and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Combining two methods for pain relief after knee surgery

    This study is testing if using a combination of a nerve block and a medication can help people feel less pain after knee surgery.

    Recruiting Kafrelsheikh University · Kafr ash Shaykh, Kafrelsheikh · NCT06837844

  • Mind mapping-based education to help after knee replacement

    A group of adults having total knee replacement will receive mind-mapping education in addition to standard care to see if it helps with pain, fear of movement, and readiness to leave the hospital.

    Recruiting Inonu University · Batman · NCT07885449

  • DoACs vs LMWH for blood flow after knee replacement

    This study tests whether rivaroxaban, apixaban, or LMWH work differently to support blood flow in the legs after total knee replacement in adults.

    Recruiting Military Hospital of Tunis · Tunis, Tunis Governorate · NCT07869615

  • Branched chain amino acids after knee replacement to help muscle

    This trial tests whether giving Livact after knee replacement helps preserve muscle and function in adults with sarcopenia.

    Recruiting at 2 sites Phase 4 Seoul National University Hospital · Seongnam-si, Gyeonggi-do and 2 other locations · NCT07634523

  • Cryotherapy to Cut Opioid Use After Knee Replacement

    This trial tests whether compressive cryotherapy with a Game Ready device can lower opioid use and improve recovery after total knee replacement in adults 60–80.

    Recruiting Hospital Italiano de Buenos Aires · Buenos Aires, Buenos Aires · NCT07630337

  • Early cognitive changes after same-day hip or knee replacement

    This study tests whether older adults (65 or older, 70 per description) who have same-day discharge after hip or knee replacement show changes in cognitive test performance from before surgery to the first day after surgery.

    Recruiting Odense University Hospital · Svendborg · NCT07598552

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.